Takeda Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

EvolveImmune Therapeuticsevolveimmune.com inOct 2024

EvolveImmune develops immunotherapy treatments for cancer patients.

BiotechHealthtechMedical DevicesBranford, US

Stephen Bloch(Co-founder and Chief Executive Officer)inDonmienne Leung(Manager)Ian Taylor(Manager)Jay Fine(President, Research and Development)

BoardDerek Yoon(Manager)in

Board seatJasmina Marjanovic· per SEC Form D

Co-investorsSolasta Ventures Pfizer Ventures Elm Street Ventures Pfizer Venture Investments

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.